Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon J Freeman

Showing results (171-180 of 348) with videos related to

Pageof 35
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2015
Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung CancerAntonio Calles, Xiaoyun Liao, Lynette M Sholl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 20, 2010
T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cellsRosemarie H DeKruyff, Xia Bu, Angela Ballesteros, et al.
Ebiomedicine|September 23, 2022
Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and functionElsa Brunet-Ratnasingham, Antigoni Morou, Mathieu Dubé, et al.
Blood|June 10, 2011
Responsiveness of HIV-specific CD4 T cells to PD-1 blockadeFilippos Porichis, Douglas S Kwon, Jennifer Zupkosky, et al.
Immunity|May 15, 2004
An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cellsLalitha Vijayakrishnan, Jacqueline M Slavik, Zsolt Illés, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2014
OX40- and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD8+ T cells to exit quiescenceSarah Buchan, Teresa Manzo, Barry Flutter, et al.
Gastroenterology|June 14, 2008
Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalizationNobuhiro Nakamoto, David E Kaplan, Jennifer Coleclough, et al.
JCI Insight|September 21, 2018
Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIVGeetha H Mylvaganam, Lynette S Chea, Gregory K Tharp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2013
PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignanciesBenjamin J Chen, Bjoern Chapuy, Jing Ouyang, et al.
Nature Communications|November 25, 2017
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunityDaniela Schmid, Chun Gwon Park, Christina A Hartl, et al.
Pageof 35

Showing results (171-180 of 348) with videos related to

Sort By:
Pageof 35
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2015
Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung CancerAntonio Calles, Xiaoyun Liao, Lynette M Sholl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 20, 2010
T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cellsRosemarie H DeKruyff, Xia Bu, Angela Ballesteros, et al.
Ebiomedicine|September 23, 2022
Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and functionElsa Brunet-Ratnasingham, Antigoni Morou, Mathieu Dubé, et al.
Blood|June 10, 2011
Responsiveness of HIV-specific CD4 T cells to PD-1 blockadeFilippos Porichis, Douglas S Kwon, Jennifer Zupkosky, et al.
Immunity|May 15, 2004
An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cellsLalitha Vijayakrishnan, Jacqueline M Slavik, Zsolt Illés, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2014
OX40- and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD8+ T cells to exit quiescenceSarah Buchan, Teresa Manzo, Barry Flutter, et al.
Gastroenterology|June 14, 2008
Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalizationNobuhiro Nakamoto, David E Kaplan, Jennifer Coleclough, et al.
JCI Insight|September 21, 2018
Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIVGeetha H Mylvaganam, Lynette S Chea, Gregory K Tharp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2013
PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignanciesBenjamin J Chen, Bjoern Chapuy, Jing Ouyang, et al.
Nature Communications|November 25, 2017
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunityDaniela Schmid, Chun Gwon Park, Christina A Hartl, et al.
Pageof 35